| Zacks Company Profile for Baxter International Inc. (BAX : NYSE) |
|
|
| |
| • Company Description |
| Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Number of Employees: 60,000 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $74.34 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 3,455,895 shares |
| Shares Outstanding: 503.53 (millions) |
| Market Capitalization: $37,432.32 (millions) |
| Beta: 0.62 |
| 52 Week High: $89.70 |
| 52 Week Low: $69.72 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-2.84% |
6.04% |
| 12 Week |
-11.98% |
-7.33% |
| Year To Date |
-13.40% |
0.95% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Jose E. Almeida - Chairman and Chief Executive Officer
James K. Saccaro - Executive Vice President and Chief Financial Offic
Brian C. Stevens - Senior Vice President; Chief Accounting Officer an
Michael F. Mahoney - Director
Nancy M. Schlichting - Director
|
|
Peer Information
Baxter International Inc. (BJCT)
Baxter International Inc. (CADMQ)
Baxter International Inc. (APNO)
Baxter International Inc. (UPDC)
Baxter International Inc. (IMTIQ)
Baxter International Inc. (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 071813109
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
|
|
Share - Related Items
Shares Outstanding: 503.53
Most Recent Split Date: 5.00 (2.00:1)
Beta: 0.62
Market Capitalization: $37,432.32 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 1.51% |
| Current Fiscal Quarter EPS Consensus Estimate: $0.88 |
Indicated Annual Dividend: $1.12 |
| Current Fiscal Year EPS Consensus Estimate: $4.16 |
Payout Ratio: 0.30 |
| Number of Estimates in the Fiscal Year Consensus: 8.00 |
Change In Payout Ratio: 0.01 |
| Estmated Long-Term EPS Growth Rate: 10.96% |
Last Dividend Paid: 02/24/2022 - $0.28 |
| Next EPS Report Date: 08/04/22 |
|
|
|
| |
